Patents by Inventor Erin DeVay Henitz

Erin DeVay Henitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Predictors for cancer treatment
    Patent number: 9322066
    Abstract: The present invention provides methods of predicting a response to a cancer treatment by determining CD68 level or PSMB1 (P11A) polymorphism in a biological sample and the presence or quantity of a second biomarker in the patient. The invention also provides kits and methods for treating cancer.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: April 26, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: Deborah Ricci, Weimin Li, Erin DeVay Henitz
  • Predictors for Cancer Treatment
    Publication number: 20130216524
    Abstract: The present invention provides methods of predicting a response to a cancer treatment by determining CD68 level or PSMB1 (P11A) polymorphism in a biological sample and the presence or quantity of a second biomarker in the patient. The invention also provides kits and methods for treating cancer.
    Type: Application
    Filed: August 8, 2012
    Publication date: August 22, 2013
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Deborah Ricci, Weimin Li, Erin DeVay Henitz